MedTrace Logo

Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19

NCT04753346 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2023-12-15

No results posted yet for this study

Summary

COVID-19 (Coronavirus disease 2019) is a new infectious disease caused by a virus named as SARS-CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2). Although it can have a devastating effect on many organs, the respiratory tract is particularly affected. In the course of the disease, a wide clinical spectrum is observed, from flu-like illness to lung failure. Some of the patients who survived the disease continue to have problems such as shortness of breath, fatigue, decrease in walking distance, decrease in participation in daily life activities. These problems suggest that the effects on respiratory and cardiac functions continue even after the disease ends. This study was designed to demonstrate the effects and extent of COVID-19 on cardiopulmonary capacity.

Conditions

  • COVID 19

Interventions

OTHER

Physical Activity Level

International Physical Activity Questionnaire

OTHER

Anxiety and Depression Assessment

Hospital Anxiety and Depression Scale

DIAGNOSTIC_TEST

Exercise Capacity

6 Minute Walk Test

DIAGNOSTIC_TEST

Pulmonary Function Test

Spirometry

DIAGNOSTIC_TEST

Cardiopulmonary Fitness Level

Cardiopulmonary Exercise Test

OTHER

Cognitive Assessment

Montreal Cognitive Assessment

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2024-01-01
Completion
2024-01-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04753346 on ClinicalTrials.gov